Jefferies Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $6.35M | Sell |
89,300
-26,000
| -23% | -$1.89M | 0.05% | 299 |
|
|
2022
Q2 | $8.88M | Buy |
115,300
+85,300
| +284% | +$6.5M | 0.07% | 217 |
|
|
2022
Q1 | $2.19M | Sell |
30,000
-120,000
| -80% | -$8.06M | 0.01% | 662 |
|
|
2021
Q4 | $9.35M | Buy |
+150,000
| New | +$8.8M | 0.05% | 285 |
|
|
2021
Q3 | – | Sell |
-40,000
| Closed | -$2.67M | – | 1719 |
|
|
2021
Q2 | $2.67M | Buy |
+40,000
| New | +$2.61M | 0.02% | 652 |
|
|
2020
Q3 | – | Sell |
-6,600
| Closed | -$388 | – | 1347 |
|
|
2020
Q2 | $388 | Sell |
6,600
-24,100
| -79% | -$1.44M | ﹤0.01% | 961 |
|
|
2020
Q1 | $1.71M | Sell |
30,700
-175,200
| -85% | -$10.7M | 0.02% | 754 |
|
|
2019
Q4 | $13.2M | Sell |
205,900
-170,300
| -45% | -$9.75M | 0.1% | 168 |
|
|
2019
Q3 | $19.1M | Sell |
376,200
-289,500
| -43% | -$13.6M | 0.15% | 89 |
|
|
2019
Q2 | $30.2M | Sell |
665,700
-2,728,900
| -80% | -$127M | 0.22% | 61 |
|
|
2019
Q1 | $162M | Buy |
3,394,600
+3,308,800
| +3,856% | +$165M | 1.33% | 10 |
|
|
2018
Q4 | $4.46M | Buy |
85,800
+4,400
| +5% | +$236K | 0.04% | 471 |
|
|
2018
Q3 | $5.05M | Buy |
81,400
+400
| +0.5% | +$23.7K | 0.03% | 524 |
|
|
2018
Q2 | $4.48M | Sell |
81,000
-586,800
| -88% | -$31.7M | 0.03% | 537 |
|
|
2018
Q1 | $42.2M | Buy |
667,800
+238,000
| +55% | +$15.3M | 0.23% | 50 |
|
|
2017
Q4 | $26.3M | Sell |
429,800
-600
| -0.1% | -$37.5K | 0.12% | 95 |
|
|
2017
Q3 | $27.4M | Sell |
430,400
-119,700
| -22% | -$6.99M | 0.18% | 84 |
|
|
2017
Q2 | $30.7M | Sell |
550,100
-789,100
| -59% | -$42.9M | 0.2% | 77 |
|
|
2017
Q1 | $72.8M | Buy |
1,339,200
+736,200
| +122% | +$40.4M | 0.54% | 17 |
|
|
2016
Q4 | $35.2M | Sell |
603,000
-819,400
| -58% | -$44.8M | 0.2% | 73 |
|
|
2016
Q3 | $76.7M | Buy |
1,422,400
+1,381,000
| +3,336% | +$88.7M | 0.4% | 32 |
|
|
2016
Q2 | $3.04M | Buy |
41,400
+25,900
| +167% | +$1.83M | 0.01% | 699 |
|
|
2016
Q1 | $990K | Sell |
15,500
-68,700
| -82% | -$4.33M | 0.01% | 1145 |
|
|
2015
Q4 | $5.79M | Buy |
84,200
+74,600
| +777% | +$4.93M | 0.03% | 406 |
|
|
2015
Q3 | $569K | Sell |
9,600
-102,000
| -91% | -$6.47M | ﹤0.01% | 1448 |
|
|
2015
Q2 | $7.43M | Sell |
111,600
-609,200
| -85% | -$40.1M | 0.04% | 382 |
|
|
2015
Q1 | $46.5M | Sell |
720,800
-331,100
| -31% | -$20.7M | 0.26% | 52 |
|
|
2014
Q4 | $62.1M | Buy |
1,051,900
+412,100
| +64% | +$23.2M | 0.36% | 55 |
|
|
2014
Q3 | $32.7M | Buy |
639,800
+499,800
| +357% | +$25M | 0.22% | 85 |
|
|
2014
Q2 | $6.79M | Buy |
140,000
+26,100
| +23% | +$1.29M | 0.06% | 286 |
|
|
2014
Q1 | $5.92M | Buy |
+113,900
| New | +$6.06M | 0.06% | 262 |
|
Other funds holding BMY
Jefferies Group's BMY Position: Q3 2022 in Review
Jefferies Group sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 44,000 shares — an estimated $3.19M sold.
Jefferies Group first reported a position in BMY in Q2 2013 and held it in 37 quarters. The position peaked at $28.4M in Q4 2016. 2,469 funds tracked by Wall St. Rank hold BMY as of Q3 2022.
- Jefferies Group reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
- Jefferies Group sold 44,000 Bristol-Myers Squibb shares in Q3 2022, an estimated $3.19M.
- Jefferies Group first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 37 quarters.
- Jefferies Group's Bristol-Myers Squibb position peaked at $28.4M in Q4 2016.
- 2,469 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.